EASD 2020: The SGLT2 Inhibitor Dapagliflozin Exerts Effects on Energy Metabolism
Parameters of energy metabolism were affected by 5 weeks of the therapy.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.